Global Atherectomy Devices Market projected to reach USD 1.93 billion by 2032
From GlobeNewswire: 2025-06-28 09:00:00
The global Atherectomy Devices Market was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.93 billion by 2032, with a CAGR of 8.16% over the forecast period. Factors driving growth include the increasing prevalence of peripheral artery disease, advancements in device technology, and a preference for minimally invasive vascular treatments.
In the U.S., the Atherectomy Devices market was valued at USD 370.50 million in 2024, projected to grow to USD 644.30 million by 2032. This growth is driven by factors such as the aging population, supportive reimbursement frameworks, and increased awareness of early PAD interventions.
Atherectomy procedures are gaining popularity globally due to advancements in technology, making them less invasive with shorter hospital stays and fewer complications. Combination interventions like atherectomy followed by drug-coated balloon angioplasty are improving procedural outcomes, with enhanced imaging and diagnostic methods aiding in early diagnosis and treatment.
Directional atherectomy devices led the market in 2024, with a share of 39.9%. They are preferred for their accuracy in plaque excision and ability to maintain vessel integrity, particularly in treating eccentric and concentric lesions in arteries like the superficial femoral. Combination interventions and cutting-edge imaging techniques have further improved treatment outcomes.
North America dominated the Atherectomy Devices market in 2024, accounting for 47.5% of global revenue. The U.S. market is a key driver due to early adoption of technology and a high volume of interventional cardiology procedures. Asia Pacific is expected to be the fastest-growing region, driven by increased cardiovascular disease prevalence and government efforts to improve vascular treatment.
Recent developments in the market include BD updating its Rotarex atherectomy system instructions, AngioDynamics launching the AMBITION BTK clinical trial for its Auryon laser system, and Cardiovascular Systems Inc. receiving expanded CE Mark approval for its Diamondback 360 Coronary Orbital Atherectomy System.
SNS Insider is a leading market research agency providing clients with current market data, consumer insights, and opinions to make confident decisions. Their report on the Atherectomy Devices Market offers comprehensive insights into market trends, key players, regional analysis, and future growth opportunities.
For more detailed information and analysis on the Atherectomy Devices Market, including segmentation by type and regional analysis, interested parties can request a briefing session with SNS Insider’s team of analysts or purchase the full report for in-depth insights and outlook for 2024-2032.
Read more at GlobeNewswire: Atherectomy Devices Market Set to Reach USD 1.93 Billion by